chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from Hoffman-LaRoche Inc. (#084505864), via a male consumer (age not reported), with concomitant medications and pertinent medical history not specified, who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (Lot# date, dose and route not reported). It was reported that on an unspecified date the patient experienced "Compromised therapy." No outcome information was provided. Additional information is not expected.
BLOOD CLOTS; This spontaneous report received from a consumer via a company representative through social media concerned a patient of unspecified age, sex, race, and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2. s (suspension for injection, route of admin, and batch number were not reported, expiry: UNKNOWN) dose, 1 total, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced blood clots, and had surgery to remove blood clots.  It was reported that " My cousin also had the J and J covid vaccine and just had surgery to remove blood clots". The action taken with covid-19 vaccine ad26.cov2. s was not applicable. The outcome of blood clots was not reported. This report was serious (Other Medically Important Condition). Sender's Comments: V0:20221047543-covid-19 vaccine ad26.cov2. s-blood clots. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and is scientifically plausible. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
This spontaneous report was received from the Vaccine Coordinator referring to a 5 year old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. On 26-OCT-2017, the patient was vaccinated with an improperly stored dose of VARIVAX with one of these lot #'s reported M017292, expiration date on 07-APR-2018; lot # N017701, expiration date on 09-JUN-2019 or with lot # N019127, expiration date on 22-JUN-2019 (Strength, route, dose, frequency, and anatomical location were unknown) for prophylaxis. There was no adverse effect reported. The administered dose of vaccine experienced the temperature excursion of 7.52 F degrees Fahrenheit for 24 hour, and had a previous temperature excursion of 5.5 F degrees Fahrenheit for 1 hour. There was a digital data logger involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA008693.
A red hard patch has risen below the injection site.  I just noticed this today.  8 days after injection.  My arm was sore for a few days but this just appeared today.
Restricted movement in shoulder. Excruciating pain. The vaccine was injected extremely high into the bursa sac. I could not move my arm above my shoulders, head, and I couldn?t twist it or move it.
Hurt all over in her legs/Hurts all over arm and under arm, wrist and elboW/Hurts across her back; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Hurt all over in her legs/Hurts all over arm and under arm, wrist and elboW/Hurts across her back) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis (for over 50 years).    In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Hurt all over in her legs/Hurts all over arm and under arm, wrist and elboW/Hurts across her back). At the time of the report, PAIN (Hurt all over in her legs/Hurts all over arm and under arm, wrist and elboW/Hurts across her back) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications were not provided. the Treatment information was not provided.
11/28/2022 that evening I began having a scratchy, sore throat when I went  to bed. On 11/30/22, I took a home COVID test and it was negative. I started having congestion in my chest and head. On 12/5/22, I went to the doctor's office. They said since my symptoms started so long ago, they would not test for COVID or flu. I was prescribed benzonatate and TUSSIN with codeine. She told me to take MUCINEX, which did not help. I called back and was prescribed cefuroxime, on 12/8/2022. I began taking it that day and am still taking it. I am much better now, a huge improvement.
Shopping, climbed a single level stairway, became winded, nauseous, got bad heartburn feeling, felt flush and started getting dizzy. Took Tums, no help went to Emergency Room and was told that there was an enzyme in my blood which showed I had a heart attack
After this booster, I felt a little tired; sore arm at injection site and slight fever. After one day, I felt better, but about a month and half later, my right arm is painful and warm at times. It seems heavy when I lift or move it.
7 pts were treated w/Engerix-B & it was determined that 4 out of 7 were non-responders;
Hives; This is a spontaneous report from a non-contactable consumer (patient).  A 48-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL9262), via an unspecified route of administration on 28Jan2021 at a single dose on the right arm for COVID-19 immunization. Medical history included asthma and postpartum cardiomyopathy on unknown dates and unknown if ongoing. The patient had allergies to sulfa and penicillin. Prior to vaccination, the patient has not had COVID-19. Concomitant medication included fexofenadine hydrochloride (ALLEGRA), carvedilol (manufacturer unknown), cefixime (FLEXERIL), losartan (manufacturer unknown) and montelukast sodium (SINGULAIR). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took Cipro, Biaxin and Ampicillin and allergies. Since the vaccination, the patient has not been tested for COVID. The patient experienced hives on 30Jan2021. The patient did not receive any treatment for the event. The patient has not recovered from the event.   No follow-up attempts are possible. No further information is expected.
Received vaccine 7/16/09. Dev rash on back 7/25 with malaise, body aches. Developed fevers to 103 on 7/28 which persisted, then developed rash on legs. The rash spread 8/3 to hands. Pain in muscles worsened. Rash became widespread by 8/10 fever, pain persisted.
The injection was my second shot of the moderna vaccine.  My first shot was on 2/13/21 and I told the facility it was only 21 days but they said it was okay.  When I gave my card to them they stamped it, and continued to send me to get my other shot.   Later that same evening my fever started fising and lowering non-stop through out the night into the next day and still today I am running fever.  It has gone anywhere from normal to 101.5 and 15 min later it can drop to 99 and a hour later back up,.  It has been like this for 48 hours now.  I am having a very hard time with my breathing but I am a copd patient and cannot tell if it is my disease or the shot.
The evening I received the shot, I started experiencing pain / soreness around the injection site. The next day I felt very strange, with flu-like symptoms all day (fever, stuffy head, body aches)
1159-Vaccinated .  1215- C/o swollen hands and headache`  1235-Symptoms improved. Allergist on call notified. Recommended PO Benadryl. Ok to take at home.
About 10 days after the vaccine was administered, the child got a red splotchy rash all over his body, mostly concentrated on the trunk (stomach and back).  Child was extremely fussy, and had a fever.  Child subsequently displayed developmental delays in speech and behavior, unsure if there is a correlation.
Tired for two days; This case was reported by a consumer via interactive digital media and described the occurrence of tiredness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced tiredness. On an unknown date, the outcome of the tiredness was recovered/resolved.   It was unknown if the reporter considered the tiredness to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 11-DEC-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient reported that be prepared for the booster of Shingles vaccine and the patient was really tired for two days after vaccination. Additional Supportive Information: Follow-up would not possible as no contact details were available.
Developed increasing palpitations, jittery sensation, and increasing anxiety. Feels like "I'm withdrawing from something"
Proquad was administered following a supported temperature excursion; This spontaneous report was received from an executive concerning a 12 month old male patient. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported.      On 28-JUN-2021, measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) suffered a supported temperature excursion at a temperature of 8.4 F degrees for 1 hour and 30 minutes (incorrect product storage).  On 23-JUL-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot # T031603, expiration date: 15-MAR-2022, as prophylaxis (strength, dose and route of administration were not reported).
experiencing the burning sensation in "weird places" ex. hand and fingers, ankle to knee; She reported a symptom of a baseball/softball side swollen knot on her L shoulder/top of arm. The knot hurt but it was tolerable.; She reported a symptom of a baseball/softball side swollen knot on her L shoulder/top of arm. The knot hurt but it was tolerable.; This is a spontaneous report from a contactable consumer (patient). A 81-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 10Mar2021 (age at the time of vaccination was 81-year-old) as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) on 17Feb2021 for COVID-19 immunization. On unspecified date, she reported a symptom of a baseball/softball side swollen knot on her L shoulder/top of arm. The knot hurt but it was tolerable. She reports putting ice packs on the knot for treatment and after 3-4 weeks it gradually got smaller. The Consumer reports that she is still experiencing the burning sensation in "weird places" ex. hand and fingers, ankle to knee. She states that the feeling doesn't bother her but just wants to know if others have reported this same symptom. Treatment included ice packs for the event "she reported a symptom of a baseball/softball side swollen knot on her L shoulder/top of arm. Outcome of the events burning sensation and Peripheral swelling was unknown while pain in arm was reported as recovering.  Information on the lot/batch number has been requested.
Headache, body aches/joint aches, fever, chills, sweating, weakness
After the vaccination I developed headaches. They where in the form of very sharp pain that could last from a few seconds to a few minutes. I had headaches everyday since the vaccination for the period of about 3 months. Never had a headache before the vaccination. Now after 6 months I have headache on average once a week.
Arm was sore for about three days.  On 12/21 evening, had headache, some lightheadedness and severe back muscle ache.  On 12/22, had stomach upset, extreme fatigue, nasal congestion.  On 12/24, had diarrhea. Fatigue continued until at least 12/29.
R upper thigh with tenderness and bruising and spherical 1 inch subcutaneous firm area, no redness or warmth superficially.
Night after injection, the site had started to swell and redden.  By the next day much swelling encircled the thigh area.  Blue blotches also appeared on thigh.  Saw ER doc that evening, he gave tylenol and benedryl told mom to apply cool compresses.  By 4/25/03 somewhat better.
Arm swelling, redness, pain.  Pain subsided and eventually ended 6 days after original injection.  Itchiness began today, 8 days after the original injection.
This spontaneous report as received from a physician via a field employee refers to a female patient of unknown age. On unknown dates the patient was vaccinated with an unspecified hepatitis A vaccine, inactivated (manufacture unknown) (dose, frequency, route and lot# not reported) series twice (vaccine administered 4 times total). On an unknown date the patient had negative titers. The patient sought unspecified medical attention via office visit. At the time of reporting, the patients outcome was unknown. Additional information has been requested.
Patient reported on social media that she was very sick after receiving the second dose of Pfizer Covid Vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "Patient reported on social media that she was very sick after receiving the second dose of Pfizer Covid Vaccine".  Additional information: Event took place after use of product  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Patient currently has a head cold with nasal congestion on 14DEC2021; Patient currently has a head cold with nasal congestion on 14DEC2021; Patient had a sore left injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Patient currently has a head cold with nasal congestion on 14DEC2021), NASAL CONGESTION (Patient currently has a head cold with nasal congestion on 14DEC2021) and VACCINATION SITE PAIN (Patient had a sore left injection site arm) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Patient had a sore left injection site arm). On 14-Dec-2021, the patient experienced NASOPHARYNGITIS (Patient currently has a head cold with nasal congestion on 14DEC2021) and NASAL CONGESTION (Patient currently has a head cold with nasal congestion on 14DEC2021). At the time of the report, NASOPHARYNGITIS (Patient currently has a head cold with nasal congestion on 14DEC2021) and NASAL CONGESTION (Patient currently has a head cold with nasal congestion on 14DEC2021) had not resolved and VACCINATION SITE PAIN (Patient had a sore left injection site arm) outcome was unknown.            The patient received their second Moderna covid-19 vaccine and had a sore left injection site arm. The patient was currently having a head cold with nasal congestion on 14-DEC-2021, at the time of the call.  No Concomitant product use was reported. No treatment information was provided.   This case was linked to MOD-2021-410335, MOD-2021-410410, MOD-2021-410457 (Patient Link).
On May 2, 2006 pt admitted to hospital with status epilepticus r/o encephalitis. Pt currently intubated continuing to have seizures. Etiology unk at this time. 5/16/06 Received medical records from PCP which reveal patient developed hard red blotch at DTaP site on 4/26/06.  No fever.  Next day developed 2 lumps on right side of neck.  Dx w/tonsillitis, cervical adenitis, pharyngitis & local reaction to DTaP.  Started augmentin.  Throat c/s gre mod Grp A strep & was to continue antibiotic.  Next contact was when admitted to PICA on 5/2/ with diagnosis of seizures.  8/21/06 Received medical records from hospital.  Patient remained hospitalized until 7/27/06 w/final diagnosis of status epilepticus & encephalopathy of unknown origin.  While hospitalized, experienced line infection w/enterovirus & c.diff colitis.  Received multiple antibiotics & antivirals. Exam by PCP revealed + strep throat & place on antibiotics.  Had fever for 4 days.  On evening of admit, very tired, sleepy & had pounding HA.  Mom had found him in bathroom covered with stool & mumbling incoherently. Then he began starring, drooling, had oral cyanosis & would not respond to verbal stimuli for approx 5 min before falling asleep.  Had continued seizures in ER (unresponsive,drooling, eyes rolled back, but no shaking.  Pupils were sluggish on admit & he had a rash.  Patient continued to have seizures & was intubated & placed into Pb coma.  Trached on 6/7/06 & G-tube placed.  PMH: negative Procedures: EEG, CT scan, MRI, LP Consults: Neuro, ID, GI (for G-tube placement), Ortho (for AFO splinting) & endocrine (due to abnormal low T3 level).  ID notes patient had MMR also prior to hospitalization & had local reaction.  Post auricle shoddy lymphadenopathy noted./ss. Pt aphasic S/P status epilepticus. Pt tracked on CPAP at night. All workup negative. Pt sent to rehabilitation.
sinus infection; This is a spontaneous report from a contactable consumer (patient). This female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient reported she received her first dose of BNT162B2 and was scheduled to receive her second dose on 06May2021. The patient stated she was currently at an appointment with a nurse practitioner regarding a sinus infection and the nurse practitioner wanted her to have a steroid injection. The patient reported that sinus infections were a "normal thing for her" and that this had nothing to do with the vaccine. The patient wanted to know if a steroid injection would interact with BNT162B2. The clinical outcome of sinus infection was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: Based on the available information the event sinus infection is attributed to an intercurrent medical condition that was not related to BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE).
For the second dose at 3 in the morning had a fever of 102.6, had body aches and headache and chills. That lasted three days straight.
per patient, vaccine given high on arm.  shoulder pain started right away and did not resolve over course of 2 weeks
fell to floor, hit head on corner of table, initially back arched-arms @ 90% angle to body w/tremors of both arms, eyes rolled back, incontinent of urine; delayed response of 20 to 30 seconds to ammonia; pt confused, crying, angry, pale;
On 12/6/2016 in the evening patient started feeling shaky. On 12/7/2016 patient developed on left arm near elbow a rash. The area felt warm to the touch and was swollen. She explained that it felt like she had extra fluid in that area.
11 days later, extreme pain in the trapezius muscle/ strain, to the point that arm was useless.  Extreme pain radiated from arm to shoulder and neck area, mimicking symptoms of stroke.
This is a spontaneous report from a contactable consumer via a Pfizer sales representative. A female patient (nurse) of an unspecified age accidentally exposed to TRUMENBA (lot number and expiration date not reported), via an unspecified route of administration on 05Jul2018 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On 05Jul2018, it was reported that as a result of the tip of the syringe breaking off when the nurse (patient) attempted to screw the needle on, her hand was nicked with the glass. Outcome of the event was unknown. Information on lot number, batch number and expiration date has been requested.
Fever for three days averaging 100 degrees. Extremely bad body aches,  weakness.  Swelling , redness and hot to the touch at the injection sit Nasea  No appetite
Fever of 100.5° F on 4/6/2021 at 12:10 a.m. Her entire body feels warmer.
pt recvd fluogen vax & exp bell's palsy; pt has exp bell's palsy's in the past; 1980 & in 1984;
Appendix ruptured 8/9/2021 in the evening, threw up all night, abdominal pain Went to hospital 8/11/2021 early in the morning Laparoscopic appendectomy IV antibiotics for several days Possible sepsis on 8/13 Atelectasis as a result of surgery Got out of the hospital 8/16, recovery lasted about 6 weeks
Case previously recorded as MA2009-4201. Initial case report received from a health care professional, via Novartis Medical Communication on 10 NOV 2009. A 3 year-old male patient was vaccinated with 0.5ml of S-OIV FLUVIRIN (batch no. 102046P1) i.m. on 05 NOV 2009. No adverse event was reported. MedCom reference no.: NA09-007859.
w/vax pt had non-stop crying spell for 3hrs beginning 2 3/4hrs p/inj;
pass out; I started feeling dizzy little bit; really feel very fatigue; I start breathing hard/barely can breathe; start seeing everything turned yellow; soaking sweating; But couldn't move; sharp pain in my stomach; This is a spontaneous report from a contactable consumer (patient). A 34-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not reported), via an unspecified route of administration, administered in Left arm on 15Apr2021 at 16:30 (at the age of 34-year-old) at single dose for COVID-19 immunisation. Medical history reported as no other medical history, no known allergies. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medications reported as none. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. After 5 min from taking the shot on 15Apr2021 at 16:35, patient started feeling dizzy little bit. He thought walking around the aisle. But he still really felt very fatigue. He wanted back and a suit and started breathing hard. He started seeing everything turned yellow and barely could breathe. Then he passed out. The stuff came and help put an alcohol by his nose. He was soaking sweating. But couldn't move. The ambulance came to check his heart, blood sugar and blood oxygen on 15Apr2021, all with unknown results. Then patient started having sharp pain in his stomach. He had lunch on 15Apr2021 at one but he had spinach broccoli and beans. Patient was healthy. He worked out four times a week. After 30 minutes of receiving care. Patient felt better but he was worry for tonight on 15Apr2021. Events resulted in Doctor or other healthcare professional office/clinic visit. Since the vaccination, patient had not been tested for COVID-19. Therapeutic measures were taken as result of event passed out included put an alcohol by his nose, treatment for the other events was unknown. The outcome of the events was unknown.  Information on the lot/batch number has been requested.